If you’ve ever felt self-conscious about your acne, you are not alone! Did you know that acne is the most common skin disease in the Philippines? It affects over 17 million people, young and old. Acne can be painful and embarrassing. It can impact self-esteem, relationships, and happiness, especially in teens. 

Clinical studies found that more than 50% of people with facial acne also had chest, shoulder, and back acne. Patients invest time and money in hygiene habits and treatment products.  The good news is that overcoming acne is possible with the proper treatment and starting it EARLY.

It is important for patients to seek treatment from a board-certified dermatologist for safe and effective prescription options like the newest retinoid innovation – Trifarotene cream.

It is an innovative topical single-agent retinoid cream proven safe and effective for acne on the face, shoulders, and back. Trifarotene cream contains the retinoid molecule, which helps the skin replace its old skin cells at a faster speed, exfoliating away the old cells in the process and preventing new acne from forming. Trifarotene works by specifically targeting the retinoic acid receptor gamma (RAR-y), the most prevalent receptor in the skin, to reduce inflammation and target the important factors that cause acne.

Trifarotene is the first new retinoid molecule to receive FDA approval for treating acne in over 25 years. It offers both dermatologists and acne patients a safe and effective prescription acne medication for the face, back, chest, and shoulders.Galderma, a world leader in developing innovative and safe dermatologist-approved skincare solutions, now brings Trifarotene to the Philippines market.  The same company gave the world well-loved brands like Cetaphil, Benzac, and Restylane, among many others. With the addition of Trifarotene to its portfolio, the company further cements its claim as one of the most innovative dermatologist-recommended skincare-focused companies in the world today.

Galderma Execom (from left to right: Khen Kon- Head of Medical JPAC, Barby Razon-Buenaventura- Brand Manager Philippines, Jade Ponoc, Rajeev Chavda-Head of Global Medical Affairs – Prescription, Luke Lee- JPAC Business Unit Head- Prescription, Ferdinand Roxas- General Manager, Philippines)

Trifarotene will only be prescribed by duly licensed healthcare practitioners, primarily dermatologists, and is recommended for patients 12 years and older.

About Galderma

Galderma, the world’s largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio to treat a range of dermatological conditions. Galderma is a leader in the research and development of scientifically-defined and medically-proven solutions for the skin. Partnering with health care practitioners around the world to meet the skin health needs of people throughout their lifetime, the company aims to change the way the world thinks about skin health. For more information, please visit www.galderma.com.